On March 26, 2025, Annovis Bio, Inc. was notified by the NYSE that it is not in compliance with listing standards due to a market capitalization of approximately $37.9 million and stockholders equity of $9.3 million, and must submit a compliance plan within 45 days to avoid delisting.